| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.03 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |